AI Can Design Viruses. Can Our Defenses Adapt Fast Enough?
AI-designed viruses are becoming a reality. Learn how programmable CRISPR could help build faster defenses against emerging and engineered viral threats.
Archive
News
All news, publications, and updates from Seek Labs.
-
-
ANINA: Molecular Accuracy Without the Laboratory.
Discover how Seek Labs developed ANINA™, a novel isothermal amplification chemistry for molecular accuracy without laboratory infrastructure.
-
BIO 2026: Where Pharma Leaders say AI Hasn’t Delivered
BIO 2026: Where Pharma leaders Say AI Hasn’t Delivered AI hasn’t always been what it was cracked up to be in pharma. Here’s where execs say the technology hasn’t lived up to the hype. SAN DIEGO — AI adoption is still ticking up in pharma with 34% of companies leveraging the tech for specific functions,…
-
Panel Discusses Future of US Public Health System After Major Federal Layoffs
Panel Discusses Future of US Public Health System After Major Federal Layoffs The future of the U.S. public health system was debated by experts on June 23 during a panel at the BIO International Convention in San Diego, as recent government restructuring and staff cuts have left agencies like the Centers for Disease Control and…
-
BIO 2026: US Public Health As We Know It Is Gone. Can We Rebuild a Better System?
Can the US public health system be rebuilt? Former FDA, CDC & NIH leaders discuss dismantling of HHS & the path to rebuilding public health.
-
The Map Isn’t the Milestone. What It Unlocks Is.
Seek Labs recently announced BioSeeker has mapped CRISPR-addressable regions across all 25 viral families known to infect humans. That is an important infectious disease milestone.
-
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping June 8, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable…
-
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing Newly issued patent covers foundational amplification chemistry designed to support sensitive molecular detection without thermal cycling or centralized laboratory infrastructure May 7, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable platforms to decode,…
-
Dr. Alison O’Mahony Named 2026 Mentor of the Year
Dr. Alison O’Mahony Named 2026 Mentor of the Year by BioHive April 28, 2026 Dr. Alison O’Mahony, Senior Vice President of Research and Development at Seek Labs, has been named Mentor of the Year as part of BioHive’s 2026 Best of BioHive Awards. The award recognizes individuals who have made exceptional contributions to mentorship and…
-
Jared Bauer Named Salt Lake City Titan 100 Honoree
Jared Bauer Named Salt Lake City Titan 100 2026 Honoree April 20, 2026 Jared Bauer, co-founder and CEO of Seek Labs, has been named a 2026 Salt Lake City Titan 100 honoree. The Titan 100 program recognizes the region’s top 100 CEOs and C-level executives, selected for their exceptional leadership, vision, and impact across industries.…
Stay connected
Follow the work as it unfolds.
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.